Early results for these knee cartilage defect patients are impressive in that the patients achieved early weight bearing.
website - https://www.askelhealthcare.com/
SUMMARY: Askel Healthcare, a Finnish medical technology company is presenting early clinical results.
The Pilot Trial has 20 patients in total, out of which 19 have now been operated. Askel has now presented a 10-patient six-month interim dataset. Key findings include immediate and sustained full weight-bearing post-surgery, significant improvements in knee function and pain levels, and high patient satisfaction with faster rehabilitation and return to pre-injury activities. The COPLA® implant, designed to treat knee cartilage defects, aims to become the global standard for surgical knee cartilage repair. The company plans to initiate a larger Pivotal Trial in 2025 to further validate these benefits.
FULL PRESS RELEASE: Askel Healthcare to Present First Clinical Trial Results of Its COPLA® Knee Cartilage Implant at the 9th Joint Preservation Congress in Warsaw, Poland on June 14-15, 2024 (press release)
Askel Healthcare to Present First Clinical Trial Results of Its COPLA® Knee Cartilage Implant at the 9th Jo...
